
World / Science & Health | FOCUS Mar 25, 2022
Drugmakers and scientists begin the hunt for long COVID treatments
Leading drugmakers, including those who have launched pills and monoclonal antibodies for COVID-19, are having early discussions with researchers about how to target the disease.